New pharmaceutical factory of Boehringer Ingelheim
The German Boehringer Ingelheim International Trading Co Ltd recently announced in Shanghai the formal establishment of a new factory of the joint venture enterprise of Shanghai Boehringer Ingelheim Pharmaceutical Company Ltd. in Shanghai. The total amount of investment was 41 million US $. It is a project highly evaluated by the government of Shanghai municipality, and was listed among one of the major project of industry in Shanghai.
The Shanghai Boehringer Ingelheim Pharmaceutical Company Ltd. is a joint venture of the German Boehringer Ingelheim International Group and the Shanghai Sine Pharmaceutical Co Ltd. Boehringer Ingelheim holds 95 % of the share. .
The factory is situated in the Pudong Zhangjian high technology garden zone, occupying an area of 34,570 m2, with the main building occupying 330 m2. The amount of production was predicted annually of 1.5 billion tablets, 6.2 million bottles of aerosol agents, one million bottles of oral agents and 1.17 million capsules of single liquid agents., http://www.100md.com
The Shanghai Boehringer Ingelheim Pharmaceutical Company Ltd. is a joint venture of the German Boehringer Ingelheim International Group and the Shanghai Sine Pharmaceutical Co Ltd. Boehringer Ingelheim holds 95 % of the share. .
The factory is situated in the Pudong Zhangjian high technology garden zone, occupying an area of 34,570 m2, with the main building occupying 330 m2. The amount of production was predicted annually of 1.5 billion tablets, 6.2 million bottles of aerosol agents, one million bottles of oral agents and 1.17 million capsules of single liquid agents., http://www.100md.com